BOSTON SCIENTIFIC CORP (BSX)

US1011371077 - Common Stock

87.55  +0.45 (+0.52%)

After market: 87.55 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

BOSTON SCIENTIFIC CORP

NYSE:BSX (10/14/2024, 8:17:22 PM)

After market: 87.55 0 (0%)

87.55

+0.45 (+0.52%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month30.03%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap128.93B
Shares
PE39.26
Fwd PE31.73
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

BSX Daily chart

Company Profile

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 48,000 full-time employees. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The firm's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.

Company Info

BOSTON SCIENTIFIC CORP

300 Boston Scientific Way

Marlborough MASSACHUSETTS 01752

P: 15086834000

CEO: Michael F. Mahoney

Employees: 48000

Website: https://www.bostonscientific.com/en-US/Home.html

BSX News

News Image12 days ago - Market News VideoS&P 500 Analyst Moves: BSX
News Image12 days ago - Market News VideoInteresting BSX Put And Call Options For November 22nd
News Image13 days ago - Boston Scientific CorporationBoston Scientific Announces Conference Call Discussing Third Quarter 2024 Results

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third...

ChartMill News Image13 days ago - ChartmillIs BOSTON SCIENTIFIC CORP Ready to Break Out of Its Range?

BOSTON SCIENTIFIC CORP (NYSE:BSX) has a good technical rating of 10 out of 10 and could possibly break out.

News Image18 days ago - Boston Scientific CorporationBoston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation System

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the...

News Image21 days ago - Market News VideoBoston Scientific Now #77 Largest Company, Surpassing Regeneron Pharmaceuticals

BSX Twits

Here you can normally see the latest stock twits on BSX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example